Professional Documents
Culture Documents
KIDNEYS
ANATO MY
21/10/15
CO
LU
M
NS
HILUS
MEDULLA
CALYCES
PYRAMIDS
RENAL PELVIS
URETER
CORTEXjA
Distinct Regions:
RENAL
MEDULLA
RENAL
CORTEX
SUMMARY
21/10/15
NEPHRONS
Functional and
Structural Unit
of the Kidneys
Each kidney contains
800 thousand to 1.2
million nephrons
Renal Corpuscles
Renal Tubules
CLASSIFIED as:
A.Cortical
B. Juxtamedullary
o Glomerulus
clusters of capillaries;
Site of Filtra1on
o Bowmans capsule
cup-shaped upper
e n d o f t h e r e n a l
tubules
Podocyte with
Basement
Membrane
Glomerulus
Bowmans Capsule
21/10/15
Renal Corpuscles
Renal Tubules
21/10/15
URINE FORMATION
21/10/15
2.Reabsorption
Solutes are reabsorbed (purple arrow) across the
wall of the nephron by transport processes, such as
active transport and cotransport.
Water is reabsorbed (green arrow) across the wall
of the nephron by osmosis.
21/10/15
Ketones: NegaMve
Protein: None
Glucose: None
RBC: None
WBC: None
Bacteria: NegaMve
pH
6.0
pH
6.8
Appearance
Clear
Appearance
Hazy
Color
Light Yellow
Color
Amber
Odor
AromaMc
Odor
AromaMc
Spec. Gravity
1.0015
Spec. Gravity
1.0020
Protein
None
Protein
Trace
RBCs
WBCs
None
2/hpf
RBCs
WBCs
2/hpf
15/hpf
URETERS
21/10/15
Ureterovesical JuncEon
Ureteropelvic JuncEon
Urinary Bladder
URETHRA
21/10/15
...Biographical Data
BIOGRAPHICAL AND
DEMOGRAPHIC DATA
Age
Gender
Marital Status
Race
OccupaMon
Geographical LocaMon
Sexual preferences/pracMces
...Symptom Analysis
...Symptom Analysis
Changes in Urine CharacterisMcs
a) Concentrated
b) Diluted
c) Hematuria
d) Pyuria
e) Proteinuria
f) Pneumaturia
...Symptom Analysis
IrritaMve/ObstrucMve ManifestaMons
5. Dysuria
1.Frequency
6. Nocturia
2.Urgency
3.Hesitancy
7. InconMnence
8. Dribbling
4.RetenMon
21/10/15
Pain
TYPE
PAIN
LOCATION CHARACTER
CVA; Flank
KIDNEY
URETERAL Radiates to
abdominal area/
umbilicus
BLADDER Suprapubic
URETHRAL Along Urethra
Dull, Constant
Severe, Sharp, Stabbing,
Colicky in nature
Dull, conMnuous
Intense with vodiing
Variable, may be during
or ager voiding
FAMILY HISTORY
CHILDHOOD DISEASES
PAST HEALTH
HISTORYLIFESTYLE,
DIET, AND WORK
HISTORY
Physical Assessment
(Urinary System)
10
21/10/15
The bell of the stethoscope maybe used
to auscultate over CVA and upper
abdominal quadrants.
The abdominal aorta and renal arteries
are auscultated for a bruit.
Physical Assessment
A l a n d m a r k u s e f u l i n
locaMng the Kidneys is the
c o s t o v e r t e b r a l a n g l e .
(Formed by the rib cage and
the vertebral column)
Lower pole of Right Kidney
is maybe palpable, smooth
and non tender, no masses
LeV Kidney is non palpable.
Laboratory Tests
Urine Studies
Blood Studies
rinalysis
U
CreaMnine Clearance
Urine Culture
11
21/10/15
Creatinine Clearance
Urinalysis
I t d e t e r m i n e / e x a m i n e t h e
p r o p e r M e s o f u r i n e
microscopically.
Procedure
Collect 24 hour urine specimen
Discard rst urinaMon when test is started.
Save urine from all subsequent urinaMons for
24 hour
Instruct paMent to urinate at the end of 24
Urine Culture
Male
Female
1. Wash hands
2. Cleanse the labia from front
to back
1. Wash hands
3. While keeping the labia
separated, void a small
2. Cleanse the meatus
amount into the toilet
3. Void a small amount
4. Without interrupMng the
into the toilet
urine stream, void directly
into the specimen container
4. Void directly into
the specimen
container
12
21/10/15
Blood Studies
Serum CreaMnine
Normal: 0.6-1.2mg/dL (males)
0.4-1.0mg/dL (females)
BUN
Normal: 6-20mg/dL (Adults)
Diagnostic Tests
Non Invasive
Invasive
Radiography
KUB
Is an x-ray examinaMon which provides informaMon
regarding the structure, size, and posi1on of abdominal
organs.
Urinary System - CalcicaMons of the renal calyces or
renal pelvis as well as any radiopaque calculi present in
the urinary tract may be visualized.
There are NO food, uid, medicaMon restricMons unless
by medical direcMon.
13
21/10/15
IVP
A test which uses IV radiopaque
contrast medium/dye to visualize
kidneys, ureters, bladder and
renal pelvis.
Post-Test
Force uids.
Assess venipuncture site for
bleeding
Monitor V/S ; U/O
Pretest
Assess for iodine sensi1vity.
Obtain consent
Inform client he will lie on a table throughout
procedure.
Administer enema the night before.
Keep the client NPO for 8 hours pretest.
Inform client about possible side eects like
throat irritaMons, ushing of face, warmth or a
salty taste that may be experienced during the
test
...MRI
It is used to visualize the Urinary
System.
It is very sensiMve in dierenMaMng
between cysts and neoplasm.
It creates a vascular map of arteries
a n d v e s s e l s w h e n u s e d
preoperaMvely.
14
21/10/15
...Ultrasonography
It can be used to evaluate the size of
the kidneys and diagnose solid
tumors and cysts.
It helps in localizing and mapping the
kidneys before biopsy.
...Urodynamic Studies
Are used to evaluate manifestaMons
of voiding dysfunc1on/abnormali1es
related to pathology of the lower
urinary tract. (Bladder and Urethra)
...Urodynamic Studies
Residual Urine (Post void Residual)
urine leV in the bladder aVer voiding
Uroowmetry
measures volume of urine voided/sec
Cystometrogram (CMG)
Evaluate bladder capacity and neuromuscular
15
21/10/15
...Endoscopy
It is used to evaluate and treat condi1ons
in the urinary tract.
Provides direct visualiza1on of the lower
urinary tract - areas not usually visible
with x-ray procedures.
Post Test
1. Observe for bright red bleeding, which is not
normal
2. Explain that burning on urinaMon, pink-Mnged
urine and urinary frequency are expected
eects.
3. Oer warm sitz baths, and mild analgesics to
relieve discomfort.
Pretest
NPO/Restrict food and uids for 8
hours.
Make sure a wri_en informed
consent has been signed prior to the
procedure and before administering
premedicaMons.
...Renal Angiography
Test which uses a radiopaque
iodine contrast material
Allows x-ray visualiza1on of the
large and small arteries of the
renal vasculature and parenchyma
or the renal veins and their
branches.
16
21/10/15
Preparation/ Procedure
Establish intravenous access. AnMcoagulants are
disconMnued.
Client should remove jewelry/metal objects
Client is posiMoned supine.
Arterial site is cleansed: Femoral artery
A radiopaque contrast material is injected through
a catheter
Rapid and series of radiographic lms are taken to
record circulaMon.
Post Test
...Renal Biopsy
It is the excision of a 1ssue sample
from the kidney for microscopic
a n a l y s i s t o d e t e r m i n e c e l l
morphology and the presence of
1ssue abnormali1es.
17
21/10/15
Pre Test
PHARMACOLOGY
Post Test
Apply pressure to the site for 5-20 minutes. Observe
site for bleeding.
Tissue samples are placed in formalin soluMon.
Closely monitor vital signs.
Blood maybe seen in the urine ager the rst few post
procedural voiding.
Monitor I and O.
Administer medica1ons. (analgesics and anMbioMcs)
DIURETICS
DIURETICS
URINARY ANALGESIC
URINARY ANTI INFECTIVES
Ac=on:
Inhibits reabsorpMon of water, potassium,
sodium and chloride in the ascending Loop of
Henle
Increasing water excreMon.
Example:
Furosemide (Lasix)
Bumetanide (Bumex)
Ac=on:
Blocks Sodium reabsorpMon in the DCT, which
prevents water reabsorpMon;
Increases urine output;
Decreases blood volume
Potassium maybe also excreted
Example:
Chlorothiazide (Diuril)
18
21/10/15
Ac=on:
Acts by blocking aldosterone receptors in the
kidneys, thus causing excreMon of water and
sodium and potassium retenMon.
Example:
Spironolactone (Aldactone)
Ac=on:
Promotes renal excreMon of sodium,
potassium, bicarbonate and water in the renal
tubules
Example:
Acetazolamide (Diamox)
DescripEons
Exert an anMbacterial eect on renal Mssue,
ureters, and bladder
Used to treat local UTI
Available in oral and IV
preparaMons
Ac=on
Acts by increasing osmo=c
pressure in the glomerular
ltrate inside the renal tubules.
This causes less reabsorpMon of
uid and electrolytes by tubules
and increased loss of uid,
chloride, and sodium.
Example:
Mannitol (Osmitrol)
Example:
Nitrofurantoin (MacrodanMn)
Sulfonamides (Sulfadiazine)
Side eects:
n/v; skin rash; CNS disturbances
Blood dyscrasias
19
21/10/15
Descrip=on
An dye excreted in the urine
which provides a topical
analgesic eect to the
urinary tract.
Example:
Phenazopyridine (Pyridium)
Side Eects
Urine may become reddishorange and can stain fabrics
Stop drug if sclera or skin
turn yellow a sign of drug
accumulaMon
Risk Factors
Female
Short, straight urethra
Proximity of meatus to vagina
to anus
Sexual Intercourse
Use of diaphragm/spermicidal
compounds for birth control
Pregnany
20
21/10/15
Risk Factors
Female
Male
Uncircumcised
ProstaMc hypertrophy
Anal intercourse
Risk Factors
Both
Aging
Urinary Tract ObstrucMon
Neurogenic bladder dysfuncMon
Vesicoureteral reux
GeneMc Factors
CatheterizaMon
PYELONEPHRITIS
It is the inammaEon of the renal pelvis
and parenchyma caused by bacterial
infecEon.
Two Main Types
a. Acute
b. Chronic
Pathophysiology
Bacteria enters the renal pelvis
Causing Inflammatory Response
Edema, Swelling,
Increased in WBC
oUrinary Obstruction
oCystitis, Neurogenic bladder
oCatheterization, Cystoscopy,
Urologic instrumentation
21
21/10/15
Clinical Findings
Subjective
Objective
vNausea and vomiMng
vLab data:
oBlood - increased WBC
oUrine increased WBC,
h e m a t u r i a , p r o t e i n u r i a ,
p o s i M v e c u l t u r e s , f o u l
smelling
oIVP may manifest structural
changes
vPain:
vank, one or both sides; dysuria, pyuria
Clinical Findings
vLoss of appeMte
vFever, chills
vUrinary frequency and urgency
vUrine cloudy, bloody, malodorous
Diagnostic Tests/Lab
Findings
1.Urinalysis and
Culture and sensitivity, (+) bacteria
2. CBC (+) WBC
3. X-ray; KUB
4. BUN, Creatinine
5. IVP, UTZ
Nursing Diagnosis
1. Altered urinary eliminaMon related
to kidney disease/infecMon
2.Pain related to inammaMon/kidney
damage
3 . H y p e r t h e r m i a r e l a t e d t o
inammaMon
Pharmacology
1. AnMbioMcs depending on the
culture and sensiMvity result
2. Analgesic (Pyridium)
3. AnMpyreMc
Nursing Outcomes/Goals
Overall goals:
1.
2.
3.
4.
5.
22
21/10/15
Nursing Interventions
Goal:
Combat infecEons, prevent recurrence,
alleviate symptoms
MedicaMons
Fluids: 1500 2000ml/day
vto ush kidneys
v relieve dysuria
v reduce fever
vto prevent dehydraMon
Nursing Interventions
Cooling measures: TSB for fever
Diet:
vSucient calories and protein to
prevent malnutriMon
v Acid-ash diet to prevent renal
calculi
vIncrease uids
Nursing Interventions
Goal: Health Teaching
Medications:
Nursing Interventions
Goal:
qPromote physical & emotional rest
AcMvity:
v Bed rest or as tolerated;
encourage ADLs as tolerated
EmoMonal support
v Encourage expression of fears,
v Include family in care; answer
quesMons
Chronic Pyelonephritis
Causes about 2 to 3% of end-stage renal disease
Personal care:
v
v
v
v
perineal hygiene,
avoid urethral contamination;
avoid tub baths
Stress the need for frequent hand washing
23
21/10/15
HYDRONEPHROSIS
HYDRONEPHROSIS
Pathophysiology
It is caused by urinary tract obstruction.
(Calculus, tumor, scar tissue, congenital
structural defects, and kink in the ureter)
Accumulating urine exerts pressure on the
renal pelvis wall
Clinical Findings
The signs and symptoms depend on the site of
obstruction, the cause and the rapidity with
which the condition developed.
The person may complain of:
vintense flank pain,
vnausea and vomiting,
voliguria, anuria and hematuria.
Palpation and percussion of abdomen may reveal
distention of the kidneys.
24
21/10/15
Nursing Outcomes
Treatment aims to:
IVP
RESULT
Nursing Diagnosis
Risk for Altered Renal Perfusion
Pain
Risk for infection related to Urinary
Stasis
Nursing Interventions/
Patient Teaching
25